Phase 3 Relapsed Small Cell Lung Cancer Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.180 enrolled1 locationNCT06496048
Recruiting
Phase 3
Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.686 enrolled1 locationNCT06128837